drugset
drugset / Trial / NCT04775615

Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Healthy Subjects.

NCT04775615 ↗

Phase 1 Unknown 36 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedSequentialQuadruple-blindTreatment

Summary

The study is being conducted to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multi-dose DDO-3055 tablets in healthy subjects for 7 days.

Timeline

Start
2021-03-17
Primary completion
2021-05-31
Completion
2021-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject DDO-3055 Small molecule — —

Indications

anemia